Transcranial Photobiomodulation Attenuates Neurogenic Inflammation and Sensory Hypersensitivity in a Nitroglycerin-Induced Migraine Model: Toward a Nonpharmacological Therapy.

This research focused on a new treatment for migraines using light therapy. Migraines cause severe headaches and sensitivity to light and touch. Current medications often do not provide full relief and can cause side effects. Researchers tested a method called transcranial photobiomodulation (PBM) on mice with migraine symptoms. They used nitroglycerin to induce migraines in the mice. The mice received light treatment on their heads for five seconds each day. The study lasted nine days, and researchers measured the mice's sensitivity to light and touch. They also examined brain changes linked to inflammation. The results showed that PBM reduced inflammation and sensitivity, suggesting it could be an effective non-drug treatment for migraines. This method could offer a safer alternative for those who struggle with current migraine medications and their side effects. Clinical relevance: This research indicates that light therapy may provide an effective, non-drug option for migraine treatment, potentially improving patient outcomes and reducing reliance on medications.